2013-09-04T12:41:36-05:00 2012-12-31 560747981 DIXON HUGHES GOODMAN LLP 500 RIDGEFIELD COURT ASHEVILLE NC 28806 990 2012-01-01 203692587 THE HAMNER INSTITUTES FOR HEALTH SCIENCE HAMN 9195581255 PO BOX 12137 RESEARCH TRIANGLE PARK NC 277092137 WILLIAM F GREENLEE 9195581255 2013-09-04 1 AMY BIBBY P00445891 8282542254 2012 2016-02-24 21:20:13Z WILLIAM F GREENLEE PO BOX 12137 RESEARCH TRIANGLE PARK NC 277092137 32560138 0 X WWW.THEHAMNER.ORG X 1977 NC TO ACCELERATE TRANSLATION AND COMMERCIALIZATION OF INNOVATIVE LIFE SCIENCE AND BIOMEDICAL RESEARCH 9 8 107 8 0 0 12495973 12253096 0 55569 52754 4669568 108536 178248 12657263 17156481 0 0 0 0 8956151 7704344 0 0 0 9319698 9354797 18275849 17059141 -5618586 97340 20206340 16215051 13476639 9392468 6729701 6822583 TO ACCELERATE TRANSLATION AND COMMERCIALIZATION OF INNOVATIVE LIFE SCIENCE AND BIOMEDICAL RESEARCH THROUGH THE DEVELOPMENT AND INTEGRATION OF CUTTING-EDGE SAFETY SCIENCE PREDICTIVE TECHNOLOGIES. 0 0 12864314 182984 PLEASE SEE SCHEDULE O FOR A FULL DESCRIPTION. 12864314 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 17 0 1 107 1 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NC X X JAMIE H WILKERSON 9195581255 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC 27709 DR CHARLES E HAMNER JR 10.00 X X 0 0 0 DR JOHN G DENT 10.00 X X 0 0 0 DR JAMES S BUS 1.00 X X 0 0 0 DR ENRIQUETA C BOND 1.00 X 0 0 0 DR GARHENG KONG 1.00 X 0 0 0 DR JOSEPH S PAGANO 1.00 X 0 0 0 DR ROBERT W RICKARD 1.00 X 0 0 0 ROBERT EUBANKS 1.00 X 0 0 0 DR WILLIAM F GREENLEE 60.00 X X 474377 0 31575 JAMIE WILKERSON 50.00 X 159962 0 12716 MELVIN ANDERSEN 50.00 X 265262 0 22257 RUSSELL THOMAS 50.00 X 237604 0 21267 HARVEY CLEWWELL III 50.00 X 178280 0 20569 RICHARD CRAVENER JR 50.00 X 108914 0 17145 DAROL DODD 50.00 X 192079 0 20714 EDWARD LECLUYSE 50.00 X 139186 0 17331 JINGBO PI 50.00 X 101626 0 11692 1857290 0 175266 9 0 1 0 MCKINSEY & COMPANY INC 55 E 52ND ST NEW YORK NY 10022 STRATEGIC PLAN CONSULTING 350000 EPL INC PO BOX 169 STERLING VA 20167 HISTOLOGY/PATHOLOGY 186157 THE REMI GROUP 11325 N COMMUNITY HOUSE RD CHARLOTTE NC 28277 MAINTENANCE 178237 PARKER POE ADAMS & BERSTEIN LLP 401 S TRYON ST CHARLOTTE NC 28202 LEGAL 149793 SCOTTINGTON QUINCY SILER 3514 ARCADIAN COURT CASTRO VALLEY CA 94546 CONSULTING 132304 10 2147944 10105152 12253096 EDUCATION COURSE 541900 55569 55569 55569 57401 57401 127415 0 127415 127415 127415 15824 20000000 0 15403657 15824 4596343 4612167 4612167 MISCELLANEOUS REVENUE 900099 50833 50833 50833 17156481 182984 0 4720401 1152505 452580 699925 5066222 4151561 914661 447574 269982 177592 592427 404220 188207 445616 340106 105510 312263 38939 273324 56690 56690 1241357 564271 677086 2867 425 2442 440864 186656 254208 384711 178163 206548 2373880 2352369 21511 115850 78166 37684 86242 34538 51704 72959 72959 882986 882986 124915 124915 LAB SUPPLIES 1440676 1377272 63404 LAB EXPENSES 1160305 1054528 105777 EQUIPMENT RENTAL/REPAIR 617211 383572 233639 MISCELLANEOUS 41021 41021 17059141 12864314 4194827 0 2865246 363291 157343 158175 2163219 1528327 50143 50021 154120 90908 9101507 6435623 3344987 2665884 11306171 11471282 52274 20206340 16215051 1335437 1178324 2336341 7292886 8115115 0 1689746 921258 13476639 9392468 X 6729701 6822583 6729701 6822583 20206340 16215051 97340 -4458 0 X X 0 1 X 1 1 1 X 20686508 14255024 16526435 12495973 12253096 76217036 20686508 14255024 16526435 12495973 12253096 76217036 25531193 50685843 514125 285043 115592 52754 68767 1036281 73012 77447 68147 108536 233817 560959 77814276 0.65140 0.57640 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8689 1349 7340 9043196 6434274 2608922 49622 49622 2665884 PENSION CONTRIBUTION PAYABLE 214612 DEFERRED COMPENSATION PAYABLE 706646 921258 X DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE CORPORATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE AND THE APPLICABLE STATE TAX STATUTES. FURTHER, THE CORPORATION HAS BEEN DETERMINED NOT TO BE A PRIVATE FOUNDATION UNDER SECTION 509(A) OF THE U.S. INTERNAL REVENUE CODE. MANAGEMENT HAS EVALUATED THE EFFECT OF THE ACCOUNTING PRINICPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA ("GAAP") GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT BELIEVES THAT THE CORPORATION AND FOUNDATION CONTINUE TO SATISFY THE REQUIREMENTS OF A TAX-EXEMPT ORGANIZATION AT DECEMBER 31, 2012. MANAGEMENT HAS EVALUATED ALL TAX POSITIONS THAT COULD HAVE A SIGNIFICANT EFFECT ON THE CONSOLIDATED FINANCIAL STATEMENTS AND DETERMINED THE CORPORATION AND FOUNDATION HAD NO UNCERTAIN INCOME TAX POSITIONS AT DECEMBER 31, 2012. THE ORGANIZATION BELIEVES IT IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR YEARS ENDED PRIOR TO DECEMBER 31, 2009. X X X X X X 0 0 0 0 0 0 0 0 0 DR WILLIAM F GREENLEE 365031 0 108306 0 1040 0 22443 0 9132 0 505952 0 0 0 JAMIE WILKERSON 133262 0 25000 0 1700 0 8607 0 4109 0 172678 0 0 0 MELVIN ANDERSEN 208833 0 40686 0 15743 0 15176 0 7081 0 287519 0 0 0 RUSSELL THOMAS 196662 0 40000 0 942 0 12135 0 9132 0 258871 0 0 0 HARVEY CLEWWELL III 177540 0 0 0 740 0 13488 0 7081 0 198849 0 0 0 DAROL DODD 171629 0 20000 0 450 0 13819 0 6895 0 212793 0 0 0 EDWARD LECLUYSE 138819 0 0 0 367 0 8124 0 9207 0 156517 0 0 0 BUILDING AND LAND LOCATED AT 6 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 2012-02-10 19763870 A REAL ESTATE APPRAISAL WAS CONDUCTED 954502084 ALEXANDRIA REAL ESTATE EQUITIES INC 385 EAST COLORADO BLVD STE 29 PASADENA CA 91101 REIT 0 0 0 0 STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENT FORM 990, PART III, LINE 4A IN FEBRUARY 2012, THE HAMNER INSTITUTES FOR HEALTH SCIENCES (THE HAMNER) AND ALEXANDRIA REAL ESTATE EQUITIES, INC. (ALEXANDRIA) FORMALLY ANNOUNCED THE LAUNCH OF THE RTP COLLABORATION CONSORTIUM, A NEW AND HIGHLY UNIQUE HUB THAT WILL BRING TOGETHER NORTH CAROLINA'S WORLD-RENOWNED UNIVERSITIES, INNOVATIVE PUBLIC AND PRIVATE COMPANIES, AND LEADING INTERNATIONAL INSTITUTIONS TO HELP SHAPE RTP AS A KEY GLOBAL CENTER FOR LIFE SCIENCE INNOVATION. WITH THE STRATEGIC ALLIANCE BETWEEN ALEXANDRIA AND THE HAMNER, THE RTP COLLABORATION CONSORTIUM IS POISED TO BECOME AN INTERNATIONAL PLATFORM FOR THE BROAD AND DIVERSE LIFE SCIENCE COMMUNITY TO COME TOGETHER TO TRANSLATE INNOVATIVE DISCOVERIES INTO SAFE AND EFFECTIVE PRODUCTS THAT ADDRESS THE MOST CRITICAL INTERNATIONAL HEALTHCARE CHALLENGES AND HELP RELIEVE THE ECONOMIC BURDEN OF DISEASE ON SOCIETY. IN APRIL 2012, THE HAMNER ANNOUNCED THAT FOUR SCIENTISTS HAVE BEEN RECOGNIZED WITH AWARDS FROM THE SOCIETY OF TOXICOLOGY, A PROFESSIONAL ORGANIZATION COMMITTED TO CREATING A SAFER AND HEALTHIER WORLD BY ADVANCING THE SCIENCE OF TOXICOLOGY AT THEIR 51ST ANNUAL MEETING THAT WAS HELD MARCH 11-15 IN SAN FRANCISCO. IN MAY 2012, AGILENT TECHNOLOGIES INC. AND A TEAM OF SCIENTISTS AND INVESTIGATORS FROM SIX LEADING RESEARCH ORGANIZATIONS, INCLUDING THE HAMNER, ANNOUNCED THE AWARDING OF A $6 MILLION GRANT FROM THE NATIONAL INSTITUTES OF HEALTH TO PIONEER TRANSFORMATIVE RESEARCH IN TOXICOLOGY. FUNDING FOR THE PROJECT COMES FROM THE COMMON FUND'S NIH DIRECTOR'S TRANSFORMATIVE RESEARCH PROJECTS PROGRAM, WHICH IS DESIGNED TO SUPPORT EXCEPTIONALLY INNOVATIVE, HIGH-RISK, ORIGINAL AND/OR UNCONVENTIONAL RESEARCH THAT HAS THE POTENTIAL TO CREATE OR OVERTURN FUNDAMENTAL SCIENTIFIC PARADIGMS. IN JUNE 2012, THE HAMNER ANNOUNCED THE FORMATION OF THE DILI-SIM INITIATIVE, A PRE-COMPETITIVE MULTI-STAKEHOLDER PARTNERSHIP THAT IT IS SPEARHEADING TO DEVELOP A COMPUTER MODELING PLATFORM TO MAKE DRUGS SAFER. THE GOALS OF THE INITIATIVE ARE TO IMPROVE PATIENT SAFETY, REDUCE THE NEED FOR ANIMAL TESTING, AND REDUCE THE COSTS AND TIME NECESSARY TO DEVELOP NEW DRUGS. IT IS THE INTENT OF THE DILI-SIM INITIATIVE TO MAKE THE MODEL, IN THE FORM OF DILISYM SOFTWARE, BROADLY AVAILABLE SO THAT IT MAY BE USED BY THE PHARMACEUTICAL INDUSTRY, THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), AND OTHER ENTITIES IN ACADEMIA, GOVERNMENT AND INDUSTRY. CURRENT INDUSTRY MEMBERS INCLUDE AMGEN, ASTRAZENECA, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, GLAXOSMITHKLINE, GILEAD, JANSSEN RESEARCH AND DEVELOPMENT, LLC, MERCK, MITSUBISHI TANABE PHARMA, NOVARTIS, PFIZER, AND SANOFI. IN SEPTEMBER 2012, IN ALIGNMENT WITH ITS VISION AND COMMITMENT TO TRANSLATIONAL LIFE SCIENCES TRAINING, THE HAMNER INSTRUCTED A ONE WEEK COURSE FOR 40 PARTICIPANTS FROM MONDAY, SEPT. 24 THROUGH FRIDAY, SEPT. 28 THAT COVERED THE APPLICATION OF COMPUTATIONAL MODELING PARADIGMS TO HUMAN HEALTH ASSESSMENTS. THE COURSE FEATURED COMPREHENSIVE LECTURES AND EXTENSIVE HANDS-ON COMPUTER MODELING PRACTICE, AND WAS DESIGNED TO SERVE A VARIETY OF SCIENTIFIC COMMUNITIES, INCLUDING INDUSTRIAL, PHARMACEUTICAL AND REGULATORY SCIENTISTS, TOXICOLOGISTS AND RESEARCH SCIENTISTS, AND INDIVIDUALS INTERESTED IN PROMOTING THE USE OF ALTERNATIVES TO LIVE ANIMAL TESTING. IN OCTOBER 2012, THE HAMNER ANNOUNCED THAT A TEAM OF RESEARCHERS WITHIN ITS INSTITUTE FOR CHEMICAL SAFETY SCIENCES, ALONG WITH COLLABORATORS AT THE U.S. ENVIRONMENTAL PROTECTION AGENCY, HAD RECEIVED THE 2012 SIMCYP ACADEMIC IVIVE AWARD FOR MOST INFORMATIVE SCIENTIFIC REPORT AT THE SIMCYP CONSORTIUM MEETING HELD SEPT 17 IN SHEFFIELD, ENGLAND. DR. BARBARA A. WETMORE, A HAMNER SENIOR RESEARCH INVESTIGATOR AND LEAD AUTHOR OF "INTEGRATION OF DOSIMETRY, EXPOSURE, AND HIGH-THROUGHPUT SCREENING DATA IN CHEMICAL TOXICITY ASSESSMENT," ACCEPTED THE AWARD AND PRESENTED THE REPORT FINDINGS TO THE CONSORTIUM MEMBERS. IN DECEMBER 2012, THE HAMNER ANNOUNCED THE ESTABLISHMENT OF A PRE-COMPETITIVE, MULTI-ORGANIZATION PARTNERSHIP DESIGNED TO PROMOTE INNOVATIVE TOXICITY TESTING RESEARCH. THE HAMNER AND BROWN UNIVERSITY WILL CONDUCT THE RESEARCH FOR THE SO-NAMED INTEGRATED BIOLOGY INITIATIVE. PARTNERS SPONSORING THE RESEARCH INCLUDE AGILENT TECHNOLOGIES INC., ILLUMINA, DOW CHEMICAL, DOW CORNING CORPORATION, EXXONMOBIL, UNILEVER AND CROPLIFE AMERICA MEMBER COMPANIES. THE LONG-RANGE RESEARCH INITIATIVE (LRI) OF THE AMERICAN CHEMISTRY COUNCIL SUPPORTED EARLIER STAGES OF THIS RESEARCH. FORM 990, PART VI, SECTION B, LINE 11 A COPY OF THE FORM 990 WAS REVIEWED BY THE FINANCE COMMITTEE PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD MAINTAINS A CONFLICT OF INTEREST POLICY WHICH IS SIGNED ON AN ANNUAL BASIS. IN THE COURSE OF MEETINGS OR ACTIVITIES, EVERYONE WILL DISCLOSE ANY INTERESTS IN A TRANSACTION OR DECISION WHERE HE/SHE (INCLUDING THEIR BUSINESS OR OTHER NON-PROFIT AFFILIATIONS, FAMILY AND/OR SIGNIFICANT OTHER, EMPLOYER OR CLOSE ASSOCIATES) MAY HAVE A CONFLICT. AFTER DISCLOSURE OF ANY POSSIBLE CONFLICT OF INTEREST, THE PERSON WILL BE ASKED TO LEAVE THE ROOM FOR THE DISCUSSION AND WILL NOT BE PERMITTED TO VOTE ON THE QUESTION. FORM 990, PART VI, SECTION B, LINE 15 HUMAN RESOURCES PREPARES MARKET ANALYSIS OF SALARY SURVEY AND OTHER DATA TO PROVIDE RECOMMENDATIONS TO THE INDEPENDENT COMPENSATION COMMITTEE, WHO REVIEWS THESE DATA ALONG WITH PERFORMANCE EVALUATIONS TO APPROVE ANY SALARY ADJUSTMENTS. DECISION AND COMPARABILITY DATA ARE DOCUMENTED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION C, LINE 18 THE ORGANIZATION'S FORM 990 IS MADE AVAILABLE TO THE PUBLIC UPON REQUEST AND ON WWW.GUIDESTAR.ORG. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST STATEMENT, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. HEALTH RESEARCH & EDUCATION FOUNDATION 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC 27709 311753977 HEALTH EDUCATION AND RESEARCH NC 501(C)(3) PF THE HAMNER INSTITUTES 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 HEALTH RESEARCH & EDUCATION FOUNDATION P 153212 FMV